Repository logo
 
Publication

Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal

dc.contributor.authorGaio, Vania
dc.contributor.authorNunes, Baltazar
dc.contributor.authorFernandes, Aida
dc.contributor.authorMendonça, Francisco
dc.contributor.authorHorta Correia, Filomena
dc.contributor.authorBeleza, Álvaro
dc.contributor.authorGil, Ana Paula
dc.contributor.authorBourbon, Mafalda
dc.contributor.authorVicente, A.M.
dc.contributor.authorMatias Dias, Carlos
dc.contributor.authorBarreto da Silva, Marta
dc.date.accessioned2014-03-13T15:17:21Z
dc.date.available2014-03-13T15:17:21Z
dc.date.issued2014-02
dc.description.abstractBACKGROUND: Metabolic syndrome (MetS) is a cluster of conditions that occur together, increasing the risk of heart disease, stroke and diabetes. Since pathways implicated in different diseases reveal surprising insights into shared genetic bases underlying apparently unrelated traits, we hypothesize that there are common genetic components involved in the clustering of MetS traits. With the aim of identifying these common genetic components, we have performed a genetic association study by integrating MetS traits in a continuous MetS score. METHODS: A cross-sectional study developed in the context of the Portuguese Component of the European Health Examination Survey (EHES) was used. Data was collected through a detailed questionnaire and physical examination. Blood samples were collected and biochemical analyses were performed. Waist circumference, blood pressure, glucose, triglycerides and high density lipoprotein cholesterol (HDL) levels were used to compute a continuous MetS score, obtained by Principal Component Analysis. A total of 37 single nucleotide polymorphisms (SNPs) were genotyped and individually tested for association with the score, adjusting for confounding variables. RESULTS: A total of 206 individuals were studied. Calculated MetS score increased progressively with increasing number of risk factors (P < 0.001). We found a significant association between CYP2C19 rs4244285 and the MetS score not detected using the MetS dichotomic approach. Individuals with the A allelic variant seem to be protected against MetS, displaying a lower MetS score (Mean difference: 0.847; 95%CI: 0.163-1.531; P = 0.015), after adjustment for age, gender, smoking status, excessive alcohol consumption and physical inactivity. An additive genetic effect of GABRA2 rs279871, NPY rs16147 and TPMT rs1142345 in the MetS score variation was also found. CONCLUSIONS: This is the first report of a genetic association study using a continuous MetS score. The significant association found between the CYP2C19 polymorphism and the MetS score but not with the individual associated traits, emphasizes the importance of lipid metabolism in a MetS common etiological pathway and consequently on the clustering of different cardiovascular risk factors. Despite the sample size limitation of our study, this strategy can be useful to find genetic factors involved in the etiology of other disorders that are defined in a dichotomized way.por
dc.description.sponsorshipThe pilot study of the Portuguese Component of the European Health Examination Survey (EHES) project has received funding from the European Commission/DG Sanco (Agreement number: 20092301 – EHES JA – EAHC). This study has also received funding from the Portuguese Foundation for Science and Technology (FCT) (Project Reference: PTDC/SAU-ESA/101743/2008)por
dc.identifier.citationDiabetol Metab Syndr. 2014 Feb 18;6(1):23. doi: 10.1186/1758-5996-6-23por
dc.identifier.issn1758-5996
dc.identifier.otherdoi:10.1186/1758-5996-6-23
dc.identifier.urihttp://hdl.handle.net/10400.18/2118
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherBioMed Central/ Brazilian Diabetes Society (SBD)por
dc.relationEHESpor
dc.relation.publisherversionhttp://www.dmsjournal.com/content/pdf/1758-5996-6-23.pdfpor
dc.subjectMetabolic Syndromepor
dc.subjectCYP2C19 genepor
dc.subjectGenetic Association Studypor
dc.subjectContinuous MetS Scorepor
dc.subjectDeterminantes da Saúde e da Doençapor
dc.subjectDoenças Cardio e Cérebro-vascularespor
dc.titleGenetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugalpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceLondon, UKpor
oaire.citation.endPage23por
oaire.citation.startPage23por
oaire.citation.titleDiabetology and Metabolic Syndromepor
oaire.citation.volume6(1)por
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1758-5996-6-23.pdf
Size:
606.24 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: